D. Thabut

D. Thabut, J. Bajaj, R. Rahimi, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Randomized Controlled Trial of the NS5A Inhibitor Daclatasvir plus Pegylated Interferon and Ribavirin for HCV Genotype-4 (COMMAND-4)

M. Buti, D. Thabut, T. Hassanein, 2015, Antiviral therapy.

Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.

D. Thabut, E. Ogier-Denis, J. Devière, 2011, Journal of hepatology.

External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B

V. de Lédinghen, D. Thabut, F. Carrat, 2022, Gastro Hep Advances.

Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).

V. de Lédinghen, Y. Ngo, M. Rudler, 2014, Journal of hepatology.

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

P. Marcellin, D. Thabut, F. Carrat, 2019, BMC Infectious Diseases.

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.

V. de Lédinghen, P. Marcellin, D. Thabut, 2019, Gastroenterology.

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France

H. Ramroth, T. Asselah, D. Thabut, 2020, Digestive Diseases and Sciences.

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

M. Manns, P. Marcellin, D. Thabut, 2014, The Lancet.

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.

P. Marcellin, D. Thabut, F. Carrat, 2017, Journal of hepatology.

Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study.

D. Thabut, D. Samuel, A. Duhamel, 2022, The lancet. Gastroenterology & hepatology.

Non‐invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study

M. Rudler, D. Thabut, T. Poynard, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease

Y. Ngo, M. Rudler, D. Thabut, 2018, Alimentary pharmacology & therapeutics.

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery

Y. Ngo, R. Andrade, M. Rudler, 2017, PloS one.

Non‐Histological Assessment of Liver Fibrosis

D. Thabut, M. Simon-Rudler, 2010 .

Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux".

Y. Ngo, D. Thabut, T. Poynard, 2009, Gastroenterologie clinique et biologique.

Biomarkers of liver fibrosis.

D. Thabut, T. Poynard, V. Ratziu, 2008, Advances in clinical chemistry.

Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.

D. Thabut, T. Poynard, V. Ratziu, 2008, Clinical biochemistry.

FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence

Y. Ngo, D. Thabut, T. Poynard, 2008, Journal of viral hepatitis.

Diagnostic value of FibroTest with normal serum aminotransferases

Y. Ngo, D. Thabut, T. Poynard, 2006, Hepatology.

Hepatitis C in 6,865 Patients 65 yr or Older: A Severe and Neglected Curable Disease?

D. Thabut, T. Poynard, V. Ratziu, 2006, The American Journal of Gastroenterology.

Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?

D. Thabut, T. Poynard, V. Ratziu, 2005, Gastroenterology.

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.

V. de Lédinghen, T. Asselah, D. Thabut, 2020, Journal of hepatology.

Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding

M. Rudler, D. Thabut, N. Ganne-Carrié, 2021, Hepatology.

A la Carte Treatment of Acute Variceal Bleeding

D. Thabut, C. Bureau, J. O’Beirne, 2016 .

Transfusion strategy in gastrointestinal bleeding: less is best?

M. Rudler, D. Thabut, 2014, Journal of hepatology.

Salvage transjugular intrahepatic portosystemic shunt followed by early transplantation in patients with Child C14‐15 cirrhosis and refractory variceal bleeding: a strategy improving survival

M. Rudler, D. Thabut, G. Rousseau, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome.

D. Thabut, D. Luton, D. Valla, 2012, Journal of hepatology.

Screening for esophageal varices

D. Thabut, S. Lemoinne, 2012, Clinical liver disease.

Noninvasive prediction of oesophageal varices: as simple as blood count?

D. Thabut, I. Gentile, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Failure to Control Bleeding and Failure to Control Rebleeding

A. Burroughs, D. Thabut, G. D’Amico, 2010 .

Screening for esophageal varices: Endoscopy, other tools, or endoscopy and other tools?

D. Thabut, R. Moreau, D. Lebrec, 2008, Hepatology.

Cost of treatment of oesophageal variceal bleeding in patients with cirrhosis in France: results of a French survey

D. Thabut, Yan Cai, N. Carbonell, 2007, European journal of gastroenterology & hepatology.

Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials.

P. Andersen, D. Thabut, G. D’Amico, 2014, Journal of hepatology.

[Variceal bleeding in patients with cirrhosis: what are the unanswered questions?].

M. Rudler, D. Thabut, J. Massard, 2008, Gastroenterologie clinique et biologique.

Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.

D. Thabut, J. Vinel, C. Bureau, 2017, Gastroenterology.

Recombinant activated factor VII in chronic liver diseases: should we be afraid of thromboembolic events?

M. Rudler, D. Thabut, T. Poynard, 2011, Journal of hepatology.

Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

M. Rudler, D. Thabut, F. Nevens, 2018, Hepatology.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, Journal of Cannabis Research.

Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis.

Y. Ngo, M. Rudler, D. Thabut, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes

Y. Ngo, D. Thabut, D. Valla, 2019, European journal of gastroenterology & hepatology.

High‐density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

D. Thabut, E. Ogier-Denis, O. Farges, 2007, Hepatology.

Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery

J. Oppert, D. Thabut, P. Bedossa, 2022, Hepatology.

Endoscopic Therapy for Variceal Bleeding: from Patient Preparation to Available Techniques and Rescue Therapies

D. Thabut, P. Sultanik, 2017, Current Hepatology Reports.

Management of acute bleeding from portal hypertension.

D. Thabut, B. Bernard-Chabert, 2007, Best practice & research. Clinical gastroenterology.

Optimal management of ascites

M. Rudler, D. Thabut, M. Mallet, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database

D. Thabut, J. Salem, B. Lebrun-Vignes, 2022, Annals of Intensive Care.

Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection

Y. Ngo, M. Rudler, D. Thabut, 2022, Gastro Hep Advances.

Elevated procalcitonin is associated with bacterial infection during acute liver failure only when unrelated to acetaminophen intoxication

M. Rudler, D. Thabut, S. Tripon, 2017, European journal of gastroenterology & hepatology.

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".

Y. Ngo, D. Thabut, D. Monneret, 2014, Clinics and research in hepatology and gastroenterology.

Transportation and handling of blood samples prior to ammonia measurement in the real life of a large university hospital.

M. Rudler, D. Thabut, Jamal Alfaisal, 2020, Clinica chimica acta; international journal of clinical chemistry.

External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease

M. Ziol, Y. Ngo, D. Thabut, 2019, GastroHep.

Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone.

D. Thabut, T. Poynard, V. Ratziu, 2004, Gut.

Long‐term Efficacy of Interferon‐Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis

D. Thabut, M. Rigon, S. Pol, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study

N. Weiss, M. Rudler, D. Thabut, 2018, Fundamental & clinical pharmacology.

Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.

M. Rudler, D. Thabut, F. Nevens, 2021, Journal of hepatology.

Pharmacokinetics/pharmacodynamics of L‐ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes

D. Thabut, J. Bajaj, K. Devarakonda, 2022, Clinical and translational science.

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

V. de Lédinghen, A. Sommet, D. Thabut, 2021, Annals of Internal Medicine.

Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus

V. de Lédinghen, D. Thabut, N. Ganne-Carrié, 2020, World journal of hepatology.

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PORTAL HYPERTENSION.

V. de Lédinghen, M. Rudler, D. Thabut, 2021, Clinics and research in hepatology and gastroenterology.

Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

M. Rudler, D. Thabut, F. Nevens, 2022, Gut.

Blood ammonia in patients with chronic liver diseases: A better defined role in clinical practice.

D. Thabut, M. Mallet, P. Sultanik, 2022, Analytical biochemistry.

A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy.

M. Rudler, D. Thabut, P. Couraud, 2021, Clinics and research in hepatology and gastroenterology.

Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.

R. Dhiman, D. Thabut, B. Sharma, 2020, The American journal of gastroenterology.

L’encéphalopathie hépatique, du diagnostic au traitement en 2016

A. Schaefer, D. Thabut, S. Tripon, 2016 .

Peak hyperammonemia and atypical acute liver failure: The eruption of an urea cycle disorder during hyperemesis gravidarum.

D. Galanaud, N. Weiss, M. Rudler, 2017, Journal of hepatology.

Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results.

M. Rudler, D. Thabut, X. Causse, 2017, Journal of hepatology.

Editorial: predicting hepatic encephalopathy after TIPSS—is multimodal cerebral MRI the answer? Authors’ reply

D. Galanaud, M. Rudler, D. Thabut, 2018, Alimentary pharmacology & therapeutics.

Efficacy and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Renal Impairment

E. Schiff, D. Thabut, S. Zeuzem, 2011, Journal of clinical pharmacology.

Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

V. de Lédinghen, E. Schiff, Y. Ngo, 2014, Journal of hepatology.

Applicability and variability of liver stiffness measurements according to probe position.

Y. Ngo, D. Thabut, D. Roulot, 2009, World Journal of Gastroenterology.

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

M. Rudler, D. Thabut, F. Nevens, 2020, Journal of hepatology.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

V. de Lédinghen, T. Asselah, D. Thabut, 2021, BMC Infectious Diseases.

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

M. Ziol, V. de Lédinghen, P. Marcellin, 2018, American heart journal.

Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis.

V. Paradis, D. Thabut, J. Taïeb, 2002, Journal of hepatology.

Portal myofibroblasts connect angiogenesis and fibrosis in liver

D. Thabut, C. Housset, S. Lemoinne, 2016, Cell and Tissue Research.

Drastic decrease of urgent endoscopies outside regular working hours during the Covid-19 pandemic in the paris area

A. Amiot, I. Sobhani, M. Rudler, 2020, Clinics and Research in Hepatology and Gastroenterology.

Progression of liver fibrosis in women infected with hepatitis C: Long‐term benefit of estrogen exposure

V. Paradis, D. Thabut, T. Poynard, 2004, Hepatology.

Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis

V. de Lédinghen, D. Thabut, R. Moreau, 2007, Hepatology.

Hepatic encephalopathy in ICU: cerebrospinal fluid metabolomics highlights alteration of multiple metabolic pathways representing new potential therapeutic targets

N. Weiss, B. Colsch, F. Isnard, 2015, Intensive Care Medicine Experimental.

Blood-brain barrier dysfunction assessed by protein S-100 beta levels in cirrhotic patients in ICU

N. Weiss, M. Rudler, D. Thabut, 2015, Intensive Care Medicine Experimental.

Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.

V. de Lédinghen, D. Thabut, C. Bureau, 2017, Journal of clinical gastroenterology.

A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC

P. Cluzel, M. Rudler, D. Thabut, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series

T. Similowski, D. Thabut, J. Derenne, 2007, BMC gastroenterology.

Treatment of portal hypertension in patients with HCC at the era of Baveno VII.

M. Kudo, D. Thabut, 2022, Journal of hepatology.

Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune‐Mediated Inflammatory Diseases

D. Thabut, F. Berenbaum, S. Pol, 2013, Arthritis care & research.

Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real‐world cohorts

V. de Lédinghen, D. Thabut, X. Forns, 2022, Journal of viral hepatitis.

Predictive value of liver damage for severe early complications and survival after heart transplantation: A retrospective analysis.

A. Pavie, P. Leprince, D. Thabut, 2018, Clinics and research in hepatology and gastroenterology.

Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient.

D. Thabut, L. Epelboin, V. Jarlier, 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndrome.

D. Thabut, H. Izzedine, G. Deray, 2009, Journal of hepatology.

Optimal nonsurgical management of peptic ulcer bleeding, including arterial embolization is associated with a mortality below 1%.

P. Cluzel, M. Rudler, D. Thabut, 2013, Clinics and research in hepatology and gastroenterology.

Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials

M. Rudler, D. Thabut, A. Denys, 2015, European journal of gastroenterology & hepatology.

Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial.

D. Thabut, G. D’Amico, J. Bosch, 2004, Gastroenterology.

Thrombolytic therapy of pulmonary embolism: a meta-analysis.

D. Thabut, H. Mal, M. Fournier, 2002, Journal of the American College of Cardiology.

Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: Results of a pilot study

D. Thabut, F. Zoulim, O. Chazouilleres, 2001, Hepatology.

Why and when to measure ammonemia in cirrhosis?

N. Weiss, M. Rudler, D. Thabut, 2018, Clinics and research in hepatology and gastroenterology.

Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

Zaibo Jiang, M. Rudler, D. Thabut, 2020, Gastroenterology.

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020

M. Rudler, D. Thabut, C. Bureau, 2020, United European gastroenterology journal.

Pre-emptive TIPS in high-risk patients with cirrhosis and variceal bleeding: is it finally time for a conclusion?

M. Rudler, D. Thabut, 2019, The lancet. Gastroenterology & hepatology.

Unsolved Questions in Salvage TIPSS: Practical Modalities for Placement, Alternative Therapeutics, and Long-Term Outcomes

M. Rudler, D. Thabut, P. Sultanik, 2019, Canadian journal of gastroenterology & hepatology.

Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients

D. Thabut, S. Varnous, F. Conti, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Adrenal insufficiency: Diagnosis in patients with liver cirrhosis is difficult

D. Thabut, A. Galbois, 2011 .

Origins and functions of liver myofibroblasts.

D. Thabut, A. Cadoret, C. Housset, 2013, Biochimica et biophysica acta.

Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure

D. Thabut, T. Poynard, V. Ratziu, 2003, Gut.

Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.

D. Thabut, T. Poynard, B. Bernard, 2001, AIDS.

Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B

D. Thabut, T. Poynard, P. Opolon, 2004, European journal of gastroenterology & hepatology.

Meta-analyses of FibroTest diagnostic value in chronic liver disease

Patrice Cacoub, Fabien Zoulim, Dominique Thabut, 2007, BMC gastroenterology.

Sequential treatment with lamivudine and interferon in patients with chronic hepatitis B non responder to interferon alone

D. Thabut, S. Pol, O. Chazouilleres, 2000 .

Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-

P. Marcellin, D. Thabut, F. Carrat, 2017, The lancet. Gastroenterology & hepatology.

Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials.

Y. Ngo, M. Rudler, D. Thabut, 2009, Gastroenterologie clinique et biologique.

Natural history and predictors of disease severity in chronic hepatitis C.

D. Thabut, T. Poynard, V. Ratziu, 2006, Journal of hepatology.

Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study

D. Thabut, J. Huraux, F. Trivin, 2003, Transplantation.

Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial.

X. Bobbia, E. Vicaut, D. Thabut, 2011, Annals of emergency medicine.

Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program

D. Thabut, F. Conti, P. Lebray, 2022, Journal of Liver Transplantation.

Meta‐analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV‐2 and ‐3 patients

D. Thabut, J. Schreiber, P. Deltenre, 2012, Alimentary pharmacology & therapeutics.

Anal Sphincter Injury After Forceps Delivery: Myth or Reality?

H. Mosnier, D. Thabut, V. Parades, 2004, Diseases of the colon and rectum.

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

T. Asselah, P. Marcellin, D. Thabut, 2019, The Lancet.

Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers

D. Thabut, D. Roulot, T. Poynard, 2008, PloS one.

Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update.

Y. Ngo, D. Thabut, T. Poynard, 2008, Gastroenterologie clinique et biologique.

An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

Y. Ngo, D. Thabut, T. Poynard, 2008, PloS one.

Baveno VII - Renewing consensus in portal hypertension.

H. Yoshiji, J. Fallowfield, V. Paradis, 2021, Journal of hepatology.

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

D. Thabut, P. Halfon, T. Poynard, 2002, Comparative hepatology.

Neurological Complications Occurring After Liver Transplantation: Role of Risk Factors, Hepatic Encephalopathy, and Acute (on Chronic) Brain Injury

N. Weiss, D. Thabut, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles

D. Thabut, A. Cadoret, G. Feldmann, 2015, Hepatology.

French Intensive Care Society, International congress – Réanimation 2016

Paul P. Tallon, Stéphane Huot, B. Souweine, 2016, Annals of Intensive Care.

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1.

D. Thabut, Y. Baruch, S. Zeuzem, 2016, World journal of gastroenterology.

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection.

Ronald Pruitt, Stefan Zeuzem, Dominique Thabut, 2016, Journal of hepatology.

Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis

D. Galanaud, L. Puybasset, N. Weiss, 2017, Metabolic Brain Disease.

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.

V. de Lédinghen, S. Imbeaud, J. Zucman‐Rossi, 2018, Gastroenterology.

Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study.

T. Asselah, D. Thabut, F. Carrat, 2021, Clinics and research in hepatology and gastroenterology.

Early TIPS with covered stents in high-risk patients with cirrhosis presenting with variceal bleeding: are we ready to dive into the deep end of the pool?

M. Rudler, D. Thabut, D. Lebrec, 2011, Journal of hepatology.

Colonic tuberculosis as a cause of massive intestinal bleeding.

M. Rudler, D. Thabut, S. Valainathan, 2020, Clinics and research in hepatology and gastroenterology.

Assessment of Liver Fibrosis: Noninvasive Means

D. Thabut, T. Poynard, V. Ratziu, 2008, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.

M. Rudler, D. Thabut, J. Vaillant, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.

Christine Katlama, Dominique Thabut, Y. Ngo, 2013, Journal of hepatology.

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

D. Thabut, B. Hainque, T. Poynard, 2004, Comparative hepatology.

Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?

D. Thabut, V. Shah, 2010, Journal of hepatology.

[Medical specialty choice: what impact of teaching? Results of a survey of two medical schools].

D. Thabut, S. Gaucher, 2013, Presse medicale.

Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding

D. Thabut, P. Kamath, V. Shah, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Diagnosis and Management of Hepatic Encephalopathy.

N. Weiss, M. Rudler, D. Thabut, 2021, Clinics in liver disease.

ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy.

M. Rudler, D. Thabut, D. Wendum, 2021, Clinics and research in hepatology and gastroenterology.

Status epilepticus in patients with cirrhosis: How to avoid misdiagnosis in patients with hepatic encephalopathy

V. Navarro, N. Weiss, M. Rudler, 2017, Seizure.

Ammonia rises from the ashes!

D. Thabut, N. Weiss, 2022, JHEP Reports.

Understanding hepatic encephalopathy

N. Weiss, D. Thabut, R. Jalan, 2018, Intensive Care Medicine.

Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis.

D. Thabut, R. Moreau, F. Saliba, 2010, Gastroenterology.

Standardization of the psychometric hepatic encephalopathy score in a French population

D. Thabut, M. Urbanski, O. Coubard, 2021, PloS one.

Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred.

M. Rudler, D. Thabut, D. Bonnefont-Rousselot, 2010, Journal of hepatology.

Letter: stepwise diagnosis in covert hepatic encephalopathy – do not forget ammonia

N. Weiss, D. Thabut, B. Hermann, 2016, Alimentary pharmacology & therapeutics.

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.

Albert Tran, Vincent Leroy, Dominique Larrey, 2018, Gastroenterology.

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19

V. Paradis, D. Thabut, D. Valla, 2022, Biomedicines.

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

D. Thabut, B. Hainque, T. Poynard, 2004, Comparative hepatology.

Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.

M. Ziol, V. de Lédinghen, J. Zucman‐Rossi, 2022, Journal of hepatology.

Model for end‐stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

D. Thabut, R. Moreau, A. Gangloff, 2007, Hepatology.

Proceedings of Réanimation 2017, the French Intensive Care Society International Congress

K. Tarte, G. Le Roux, D. Boels, 2017, Annals of Intensive Care.

Precision Bariatric/Metabolic Medicine and Surgery

D. Thabut, L. Genser, J. Aron‐Wisnewsky, 2023, Journal of clinical medicine.

Improved Prognosis of Septic Shock in Patients With Cirrhosis: A Multicenter Study*

D. Thabut, B. Guidet, P. Aegerter, 2014, Critical care medicine.

Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.

D. Thabut, A. Duhamel, J. Salleron, 2013, JAMA.

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C

D. Thabut, T. Poynard, V. Ratziu, 2004, Hepatology.

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis

K. Glaser, D. Thabut, V. Shah, 2011, Hepatology.

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

V. de Lédinghen, D. Thabut, B. le Bail, 2006, BMC gastroenterology.

MetaboRank: network-based recommendation system to interpret and enrich metabolomics results

Fabien Jourdan, Benoit Colsch, Florence Vinson, 2018, Bioinform..

Aggressive management of nonocclusive ischemic colitis following aortic reconstruction.

D. Thabut, J. Rouby, E. Kieffer, 2006, Archives of surgery.

FOUR Score, a Reliable Score for Assessing Overt Hepatic Encephalopathy in Cirrhotic Patients

N. Weiss, M. Rudler, D. Thabut, 2015, Neurocritical Care.

Portal hypertension, advanced hepatocellular carcinoma and therapy by atezolizumab-bevacizumab: a "menage à trois" !

M. Rudler, D. Thabut, M. Wagner, 2021, Clinics and research in hepatology and gastroenterology.

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

Y. Ngo, D. Thabut, T. Poynard, 2006, Clinical chemistry.

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

D. Thabut, T. Poynard, V. Ratziu, 2004, Clinical chemistry.

Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial

D. Thabut, G. D’Amico, J. Bosch, 2008, Hepatology.

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

Chris Day, Fritz Wrba, Debbie Lawlor, 2016, Alimentary pharmacology & therapeutics.

Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population.

D. Thabut, G. D’Amico, F. Bendtsen, 2010, Journal of hepatology.

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

Dominique Thabut, Mohamed Tahiri, V. de Lédinghen, 2006, BMC gastroenterology.

Hepatic encephalopathy: Another brick in the wall.

N. Weiss, D. Thabut, C. Housset, 2019, Journal of hepatology.

External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV

V. de Lédinghen, D. Thabut, F. Carrat, 2021, JHEP reports : innovation in hepatology.

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.

D. Thabut, F. Capron, T. Poynard, 2005, Clinical Gastroenterology and Hepatology.

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

D. Thabut, T. Poynard, V. Ratziu, 2009, European journal of gastroenterology & hepatology.

Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.

M. Rudler, D. Thabut, T. Poynard, 2015, Journal of hepatology.

Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication

V. de Lédinghen, P. Marcellin, E. Letouzé, 2018, Hepatology.

Model for end‐stage liver disease exceptions in the context of the french model for end‐stage liver disease score–based liver allocation system

D. Thabut, R. Moreau, D. Samuel, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patients.

M. Rudler, D. Thabut, M. Rouprêt, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding

M. Rudler, D. Thabut, J. Golmard, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Covered Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension : Looking for the Right Patient and the Right Time

D. Thabut, J. Trebicka, M. Senzolo, 2018 .

Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison

Y. Ngo, D. Thabut, H. Perazzo, 2016, PloS one.

Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis

P. Cluzel, Y. Ngo, M. Rudler, 2015, PloS one.

The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.

D. Thabut, R. Moreau, J. Taieb, 2006, Journal of hepatology.

Noninvasive assessment of portal hypertension in patients with cirrhosis

D. Thabut, R. Moreau, D. Lebrec, 2011, Hepatology.

Variceal bleeding in cirrhotic patients

M. Rudler, D. Thabut, M. Mallet, 2017, Gastroenterology report.

Biomarkers as non‐invasive assessment of hepatic fibrosis in chronic hepatitis C

D. Thabut, T. Poynard, V. Ratziu, 2004 .

Noninvasive prediction of fibrosis in patients with chronic hepatitis C

D. Thabut, T. Poynard, R. Myers, 2003, Hepatology.

284 Diagnostic value of fibrosis biochemical markers (fibrotest) for the screening of oesophageal varices in patients with chronic liver disease

D. Thabut, M. Munteanu, J. Moussalli, 2003 .

FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.

V. de Lédinghen, D. Thabut, T. Poynard, 2011, Clinics and research in hepatology and gastroenterology.

Improvement in the prognosis of cirrhotic patients admitted to an intensive care unit, a retrospective study

D. Thabut, P. Böelle, B. Guidet, 2012, European journal of gastroenterology & hepatology.

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B

Y. Ngo, D. Thabut, T. Poynard, 2011, Current hepatitis reports.

Portal myofibroblasts connect angiogenesis and fibrosis in liver

D. Thabut, C. Housset, S. Lemoinne, 2016, Cell and Tissue Research.

Diagnosis of minimal hepatic encephalopathy in patients with cirrhosis: Should we bury psychometric tests?

N. Weiss, D. Thabut, K. Kinugawa, 2014, Hepatology.

P: 65 Drug-induced Hyperammonaemia: Data From VigiBase, the WHO Database

N. Weiss, M. Rudler, D. Thabut, 2019, American Journal of Gastroenterology.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Early liver transplantation for severe alcoholic hepatitis not responding to medical treatment: results of the French-Belgian prospective study QuickTrans

D. Thabut, D. Samuel, A. Duhamel, 2020 .

Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats

M. Rudler, D. Thabut, R. Moreau, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Beta‐blockers have no effect on outcomes in patients with cirrhosis and severe infections

D. Thabut, B. Guidet, H. Ait-Oufella, 2011, Hepatology.

Diagnosis and management of hepatic encephalopathy: The French recommendations

V. de Lédinghen, D. Galanaud, M. Rudler, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance

V. de Lédinghen, T. Asselah, D. Thabut, 2021, JHEP Reports.

Metabolomics in the understanding and management of hepatic encephalopathy.

B. Colsch, M. Rudler, D. Thabut, 2021, Analytical biochemistry.

TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.

M. Rudler, D. Thabut, T. Sauerbruch, 2023, Journal of hepatology.

Prognostic value of liver fibrosis biomarkers: a meta-analysis.

Y. Ngo, D. Thabut, H. Perazzo, 2011, Gastroenterology & hepatology.

Non‐virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort

P. Marcellin, E. Letouzé, D. Thabut, 2019, Journal of viral hepatitis.

THU-151-Real-world effectiveness and safety of glecaprevir plus pibrentasvir in HCV: A multi-country analysis of postmarketing observational studies

D. Thabut, P. Lampertico, M. Bondin, 2019, Journal of Hepatology.

Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?

M. Rudler, D. Thabut, T. Poynard, 2015, European journal of gastroenterology & hepatology.

Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.

D. Thabut, F. Conti, B. Barrou, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding

M. Rudler, D. Thabut, J. Golmard, 2015, Hepatology.

Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.

N. Weiss, D. Thabut, Julie Assaraf, 2017, Gastroenterology.

Liver biopsy: the best standard...when everything else fails.

D. Thabut, T. Poynard, V. Ratziu, 2009, Journal of hepatology.

M. Rudler, D. Thabut, F. Nevens, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Early use of TIPS for cirrhosis and variceal bleeding.

M. Rudler, D. Thabut, T. Poynard, 2010, The New England journal of medicine.

Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C

D. Thabut, A. Galbois, G. H. Pitié-Salpêtrière, 2011 .

Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.

R. Dhiman, D. Thabut, B. Sharma, 2020, The American journal of gastroenterology.

Management of gastric varices: a French national survey

M. Rudler, D. Thabut, C. Bureau, 2016, European journal of gastroenterology & hepatology.

Letter: improve survival after variceal bleeding in cirrhosis—place pTIPS as early as possible after index bleed

M. Rudler, D. Thabut, J. García‐Pagán, 2023, Alimentary pharmacology & therapeutics.

Combined diffusion tensor imaging and magnetic resonance spectroscopy to predict neurological outcome before transjugular intrahepatic portosystemic shunt

D. Galanaud, N. Weiss, R. Valabrègue, 2018, Alimentary pharmacology & therapeutics.

Parvovirus B19 infection: A challenging cause of fulminant hepatitis.

M. Rudler, D. Thabut, D. Samuel, 2020, Clinics and research in hepatology and gastroenterology.

Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.

D. Thabut, S. Dharancy, D. Capron, 2008, European journal of internal medicine.

Liver damage associated with Covid-19: A direct causality is difficult to establish

M. Rudler, D. Thabut, M. Mallet, 2021, Journal of Liver Transplantation.

Expression of Granzyme B in viral hepatitis in patients with ALPS

D. Thabut, T. Poynard, V. Ratziu, 2004, Hepatology.

The Predictive Value of Fibrotest vs . APRI for the Diagnosis of Fibrosis in Chronic Hepatitis C To the

Lau, M., D. Thabut, 2004 .

Diagnosis and Management of Hepatic Encephalopathy.

M. Rudler, D. Thabut, C. Bouzbib, 2021, Clinics in liver disease.

Magnetic resonance spectroscopy: A surrogate marker of hepatic encephalopathy?

D. Galanaud, N. Weiss, M. Rudler, 2019, Journal of hepatology.

Hepatic vs. drug‐induced encephalopathy in cirrhotic patients?

N. Weiss, M. Rudler, D. Thabut, 2016, Liver international (Print).

Management of liver failure in General Intensive Care Unit.

R. Amathieu, D. Thabut, S. Jaber, 2020, Anaesthesia, critical care & pain medicine.

Management of Complications of Portal Hypertension

M. Rudler, D. Thabut, P. Bittencourt, 2019, Canadian Journal of Gastroenterology and Hepatology.

Combination of MELD and lactate predicts death in patients treated with salvage TIPS for refractory variceal bleeding.

M. Rudler, D. Thabut, N. Ganne-Carrié, 2021, Hepatology.

Letter to the Editor: Salvage TIPS in Patients With Cirrhosis With Variceal Bleeding: MELD, Lactates, and “à la Carte” Decision

D. Thabut, C. Bureau, J. García‐Pagán, 2021 .

Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors

D. Thabut, F. Goldwasser, S. Pol, 2023, JHEP reports : innovation in hepatology.

Diagnosis and Management of Hepatic Encephalopathy

M. Rudler, D. Thabut, C. Bouzbib, 2021, Springer International Publishing.

PrednisoloneWith vsWithout Pentoxifylline and Survival of PatientsWith Severe Alcoholic Hepatitis

D. Thabut, A. Duhamel, J. Salleron, 2013 .

Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding

M. Rudler, D. Thabut, J. Golmard, 2015, Hepatology.

Preemptive-TIPS improves outcome in high-risk variceal bleeding An observational study

M. Rudler, D. Thabut, F. Nevens, 2018 .

Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)

V. de Lédinghen, J. Zucman‐Rossi, D. Thabut, 2023, Quality of Life Research.

Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial.

X. Bobbia, E. Vicaut, D. Thabut, 2011, Annals of emergency medicine.

Efficacy of activated recombinant factor VII (RFVIIA; Novoseven®) in cirrhotic patients with upper gastrointestinal bleeding: A randomised placebo-controlled double-blind multicenter trial

D. Thabut, F. Bendtsen, R. Franchis, 2003 .

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis

K. Glaser, D. Thabut, V. Shah, 2011, Hepatology.

819Daclatasvir in Combination with Peginterferon Alfa-2a and Ribavirin for Treatment-Naive Patients with HCV Genotype 4 Infection: Phase 3 COMMAND-4 Results

M. Buti, D. Thabut, T. Hassanein, 2014 .

CT Scan Is Still a Valuable Tool to Assess Hepatic Encephalopathy Pathophysiology in Both Acute and Chronic Liver Diseases.

N. Weiss, D. Thabut, 2018, Critical care medicine.

To perform or not to perform liver biopsy: an alternative view

D. Thabut, T. Poynard, V. Ratziu, 2003, Gut.

Triple Therapy for Hepatitis C Virus Infection in Patients Receiving Hemodialysis

D. Thabut, B. Barrou, S. Lemoinne, 2014, Annals of Internal Medicine.

Altered distal‐proximal temperature gradient as a possible explanation for sleep‐wake disturbances in cirrhotic patients

N. Weiss, D. Thabut, V. Attali, 2017, Liver international : official journal of the International Association for the Study of the Liver.

AASLD Practice Guidance on the Use of TIPS, Variceal Embolization, and Retrograde Transvenous Obliteration in the Management of Variceal Hemorrhage.

Edward A. Lee, D. Thabut, S. Kalva, 2023, Hepatology.

Difficulties in assessing portal hypertension in case of HVB-HVD co infection.

D. Thabut, P. Lebray, M. Allaire, 2023, Clinics And Research in Hepatology and Gastroenterology.

Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma

M. Rudler, D. Thabut, M. Wagner, 2023, Alimentary pharmacology & therapeutics.

Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab

D. Thabut, P. Nahon, N. Ganne-Carrié, 2023, Hepatology.

Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

M. Rudler, D. Thabut, G. Han, 2023, Hepatology.

Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management

D. Thabut, M. Allaire, 2023, Hepatology.

ABC of the Upper Gastrointestinal Tract

D. Thabut, T. Poynard, V. Ratziu, 2003 .

Biomarkers of liver fibrosis.

D. Thabut, T. Poynard, V. Ratziu, 2008, Advances in clinical chemistry.

Posters (Abstracts 289–2348)

D. Thabut, F. Nevens, M. Casas, 2019, Hepatology.